Skip to content

Effect of improved intraocular lenses on contrast sensitivity tests.

Effect of improved intraocular lenses on contrast sensitivity tests.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON23838
Enrollment
60
Registered
2006-11-20
Start date
2006-11-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Each patient will receive a spherical IOL in one eye and an aspherical IOL in the fellow eye. The spherical IOL is normally used, the aspherical is not. The IOL's are CE approved.

Interventions

Two groups of 30 patients, each group tested with a specific intraocular lens (IOL) type in a spheric and aspheric design. In each patient a spherical IOL is placed in one eye and an aspherical IOL in

Sponsors

University Hospital Groningen, department ophtalmology Hanzeplein 1 Postbus 30.001 9700 RB Groningen The Netherlands Tel: (+31)050-3612510 Fax: (+31)050-3611709 AMO (advanced medical optics) Groningen B.V. Van Swietenlaan 5 9728 NX Groningen Tel: (+31)050-5296600 Fax: (+31)050-5267860
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Cataract in both eyes.

Exclusion criteria

Exclusion criteria: 1. Other ocular pathology as diabetic, macula degeneration and glaucoma; 2. Cylinder larger than 1,5 D; 3. Medication that influences the tear function of the eye; 4. Pathology that influences the tear production; 5. Prevalance of pathology between the two cataract operations; 6. Younger than 18 years; 7. Prevalance of senile dementia (MMSE<22).

Design outcomes

Primary

MeasureTime frame
Improvement of the contrast sensitivity in the aspheric IOL.

Secondary

MeasureTime frame
1. No decrease of depth of focus. 2. No difference in intraocular stray light.

Contacts

Public ContactK.W. Gaalen, van

University Medical Center Groningen (UMCG), Department Ophtalmology, P.O. box 30.001

k.van.gaalen@ohk.umcg.nl+31 (0)50 3619692

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)